Bisomax 5 mg Johnlee Pharmaceuticals

£8.00

Bisomax 5 mg tablets represent Johnlee Pharmaceuticals’ research-grade bisoprolol formulation for cardiovascular studies. Each tablet contains 5 mg of pharmaceutical-grade bisoprolol for laboratory investigations only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Bisomax 5 mg Johnlee Pharmaceuticals
Bisomax 5 mg Johnlee Pharmaceuticals
£8.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Cardiovascular Research Applications

Bisomax 5 mg is a selective beta-1 adrenergic receptor antagonist manufactured by Johnlee Pharmaceuticals for in-vitro research applications. Bisoprolol is a cardioselective beta-blocker that researchers can examine for its receptor binding properties and cardiovascular pharmacology studies. This compound demonstrates high selectivity for beta-1 receptors over beta-2 receptors in preclinical models, making it valuable for investigators studying cardiac-specific adrenergic modulation.

Laboratory Investigation Protocols

Research teams at Stroid UK Shop investigate Bisomax 5 mg in controlled environments to analyse beta-adrenergic receptor interactions. The compound’s molecular formula C18H31NO4 and molecular weight of 325.44 g/mol provide researchers with consistent parameters for analytical studies. Scientists can evaluate the compound’s binding kinetics, receptor selectivity profiles, and pharmacokinetic properties in appropriate research models. Studies examine bisoprolol’s tissue distribution patterns and metabolic pathways for comprehensive cardiovascular research protocols.

Research Compound Specifications

Bisomax 5 mg Technical Data for Research
Parameter Specification
Active Ingredient Bisoprolol
Strength 5 mg per tablet
Manufacturer Johnlee Pharmaceuticals
Form Oral tablets
CAS Number 66722-44-9
Molecular Formula C18H31NO4
Storage Requirements Room temperature, dry environment

Research teams utilising this compound should store tablets in controlled laboratory conditions away from moisture and direct light. The pharmaceutical-grade formulation ensures consistent potency for research applications. Investigators studying cardiovascular pharmacology often compare this compound with other beta-blockers available through selective receptor modulators and peptide research compounds to understand receptor specificity patterns.

Research-Only Compliance Statement

Bisomax 5 mg by Johnlee Pharmaceuticals is manufactured exclusively for in-vitro research and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory protocols when handling this compound and ensure compliance with institutional research guidelines and local regulations governing research chemical use.

Related